Integra Holdings

A holding company focusing on biopharmaceutical companies based on inventions of researchers from the Hebrew University of Jerusalem.

Venture Capital Active Jerusalem, Israel Est. 2012
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
5
in our dataset
Rounds participated
6
Rounds led
0
Rounds' value
$40.0M
total disclosed, rounds participated
Stages
C Round, A Round, Seed, E Round, F Round, B Round, D Round, Pre-Seed, G Round

About

Integra Holdings is a healthcare investment company that acts as a commercialization vehicle for the Hebrew University of Jerusalem. It focuses on translating faculty research into investable life-science companies, with an exclusive right to examine innovations and intellectual property emerging from the university. Integra Holdings provides funding, strategic planning, business development, and R&D guidance to its portfolio companies, which operate in diverse therapeutic fields such as oncology, Alzheimer's disease, infectious diseases, and allergies. The company's portfolio includes companies in preclinical to late stages of development, with a focus on pharma biotechnology, medical devices, diagnostics, and AI applied to healthcare.

Portfolio · 5

Rebiotics Rx
Repurposing Existing Antibiotics to Fight Antibiotic-resistant Bacteria
1 round Latest: 2018-10
BacoCure
Bacterial Products for Treatment of Non-muscle Invasive Bladder Cancer
1 round Latest: 2018-02
Atox Bio
Immunomodulators for Treatment of Infectious and Inflammatory Diseases
1 round $30.0M committed Latest: 2017-12
Avraham Pharmaceuticals
Prevention of Neurodegenerative Disorders
2 rounds $8.5M committed Latest: 2016-02
Tiltan Pharma
Anti-angiogenic and Immune Modulatory Platforms for Cancer Treatment
1 round $1.5M committed Latest: 2014-02

Investment activity

Portfolio by sector

Health Tech & Life Sciences14

Q&A

What is Integra Holdings' primary investment focus?
Integra Holdings is a healthcare investment company with an exclusive first right to examine innovations and intellectual property from the Hebrew University of Jerusalem. Their focus is on biopharmaceuticals, medical diagnostics, and devices.
Which stages of investment does Integra Holdings typically engage in?
Integra Holdings invests across various stages, including Pre-Seed, Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
Can you name some of Integra Holdings' notable portfolio companies?
Integra Holdings' portfolio includes companies such as Atox Bio, which focuses on immunomodulators, and SpliSense, which develops RNA-based treatments for genetic diseases.
What is the most recent investment round Integra Holdings participated in?
Integra Holdings participated in an investment round in April 2024.
What is Integra Holdings' approach to supporting its portfolio companies?
Integra Holdings provides know-how and support to its portfolio companies from inception to commercialization, leveraging its extensive industry network and employing multidisciplinary teams of experts.
Who are the key shareholders of Integra Holdings?
Integra Holdings' shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli institutional funds such as the Israeli Teachers and Kindergarten Study funds.
What is the total amount raised by portfolio company Atox Bio?
Atox Bio, a portfolio company of Integra Holdings, has raised $64.85 million in funding.
What is the total amount raised by portfolio company SpliSense?
SpliSense, a portfolio company of Integra Holdings, has raised $41.5 million in funding.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)